Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)

NCT00799773 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Low enrollment rate

Conditions

Thrombotic Thrombocytopenic Purpura

Interventions

DRUG: Rituximab
PROCEDURE: Plasma exchange
DRUG: Corticosteroids

Sponsor

Carelon Research

Collaborators

[object Object]
[object Object]